Back to User profile » Mr Dominic Pilon
Papers published by Mr Dominic Pilon:
Real-World Clinical and Economic Outcomes Among Patients with Localized Prostate Cancer Undergoing Radical Prostatectomy Across Different Risk Stratifications in the United States
Shore N, Lowentritt B, Patel C, Burbage S, Kinkead F, Rossi C, Lee F, Pilon D, Karsh L, Brown G
ClinicoEconomics and Outcomes Research 2026, 18:590934
Published Date: 27 May 2026
Prescriber- and Patient-Level Characteristics Associated with Patient Adherence to Any Antipsychotics Among Patients with Schizophrenia in the United States
Voegel A, Naranjo RR Jr, Diaz L, Vanden Eynde C, Wang Y, Pilon D, Benson C, Citrome L
Patient Preference and Adherence 2026, 20:570441
Published Date: 17 February 2026
Homologous Recombination Repair Testing Patterns and Outcomes in mCRPC by Alteration Status and Race
Bilen MA, Khilfeh I, Rossi C, Muser E, Morrison L, Hilts A, Diaz L, Lefebvre P, Pilon D, George DJ
ClinicoEconomics and Outcomes Research 2024, 16:657-674
Published Date: 6 September 2024
Real-World Maintenance Phase Persistence on Ustekinumab and Adalimumab in Ulcerative Colitis
Zhdanava M, Kachroo S, Shah A, Ding Z, Lefebvre P, Zhao R, Kerner C, Pilon D
Patient Preference and Adherence 2024, 18:809-820
Published Date: 10 April 2024
Impact of COVID-19 Pandemic on Prescribing of Long-Acting Injectable Antipsychotics for Schizophrenia: Results from a United States Prescriber Survey
Zhdanava M, Starr HL, Totev TI, Lefebvre P, Shah A, Sheng K, Pilon D
Neuropsychiatric Disease and Treatment 2022, 18:2003-2019
Published Date: 7 September 2022
Understanding the Health System Conditions Affecting the Use of Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia in Clinical Practice: A US Healthcare Provider Survey
Zhdanava M, Starr HL, Lefebvre P, Totev TI, Shah A, Sheng K, Pilon D
Neuropsychiatric Disease and Treatment 2022, 18:1479-1493
Published Date: 22 July 2022
A retrospective study to assess clinical characteristics and time to initiation of open-triple therapy among patients with chronic obstructive pulmonary disease, newly established on long-acting mono- or combination therapy
Mapel D, Laliberté F, Roberts MH, Sama SR, Sundaresan D, Pilon D, Lefebvre P, Duh MS, Patel J
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1825-1836
Published Date: 21 June 2017
Treatment patterns in Medicaid patients with schizophrenia initiated on a first- or second-generation long-acting injectable versus oral antipsychotic
Pilon D, Joshi K, Tandon N, Lafeuille M, Kamstra RL, Emond B, Lefebvre P
Patient Preference and Adherence 2017, 11:619-629
Published Date: 23 March 2017